Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizaveta Rabushko

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Therapeutic Advances in Medical Oncology|January 5, 2023
Clinically relevant fusion oncogenes: detection and practical implicationsMaksim Sorokin, Elizaveta Rabushko, Julian Markovich Rozenberg, et al.
Biomedicines|August 26, 2022
Experimentally Deduced Criteria for Detection of Clinically Relevant Fusion 3' Oncogenes from FFPE Bulk RNA Sequencing DataElizaveta Rabushko, Maxim Sorokin, Maria Suntsova, et al.
Frontiers in Molecular Biosciences|December 10, 2021
Experimental and Meta-Analytic Validation of RNA Sequencing Signatures for Predicting Status of Microsatellite InstabilityMaksim Sorokin, Elizaveta Rabushko, Victor Efimov, et al.
Frontiers in Oncology|September 16, 2021
RNA Sequencing for Personalized Treatment of Metastatic Leiomyosarcoma: Case ReportAlexander Seryakov, Zaynab Magomedova, Maria Suntsova, et al.
Frontiers in Oncology|October 15, 2021
RNA Sequencing Data for FFPE Tumor Blocks Can Be Used for Robust Estimation of Tumor Mutation Burden in Individual BiosamplesMaxim Sorokin, Alexander Gorelyshev, Victor Efimov, et al.
Computers in Biology and Medicine|February 8, 2026
Insertional activity of human Alu and L1 retrotransposons is associated with DNA repair pathways and genome instability in cancerMaria Suntsova, Alexander Modestov, Elizaveta Rabushko, et al.
Cancers|November 27, 2024
A New Approach of Detecting <i>ALK</i> Fusion Oncogenes by RNA Sequencing Exon Coverage AnalysisGalina Zakharova, Maria Suntsova, Elizaveta Rabushko, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Therapeutic Advances in Medical Oncology|January 5, 2023
Clinically relevant fusion oncogenes: detection and practical implicationsMaksim Sorokin, Elizaveta Rabushko, Julian Markovich Rozenberg, et al.
Biomedicines|August 26, 2022
Experimentally Deduced Criteria for Detection of Clinically Relevant Fusion 3' Oncogenes from FFPE Bulk RNA Sequencing DataElizaveta Rabushko, Maxim Sorokin, Maria Suntsova, et al.
Frontiers in Molecular Biosciences|December 10, 2021
Experimental and Meta-Analytic Validation of RNA Sequencing Signatures for Predicting Status of Microsatellite InstabilityMaksim Sorokin, Elizaveta Rabushko, Victor Efimov, et al.
Frontiers in Oncology|September 16, 2021
RNA Sequencing for Personalized Treatment of Metastatic Leiomyosarcoma: Case ReportAlexander Seryakov, Zaynab Magomedova, Maria Suntsova, et al.
Frontiers in Oncology|October 15, 2021
RNA Sequencing Data for FFPE Tumor Blocks Can Be Used for Robust Estimation of Tumor Mutation Burden in Individual BiosamplesMaxim Sorokin, Alexander Gorelyshev, Victor Efimov, et al.
Computers in Biology and Medicine|February 8, 2026
Insertional activity of human Alu and L1 retrotransposons is associated with DNA repair pathways and genome instability in cancerMaria Suntsova, Alexander Modestov, Elizaveta Rabushko, et al.
Cancers|November 27, 2024
A New Approach of Detecting <i>ALK</i> Fusion Oncogenes by RNA Sequencing Exon Coverage AnalysisGalina Zakharova, Maria Suntsova, Elizaveta Rabushko, et al.
Pageof 1